OxyContin® to be removed from formulary Jan. 1, 2026

Effective Jan. 1, 2026, OxyContin® will be removed from coverage under the pharmacy benefit  for commercial group and individual members. The generic for OxyContin, Oxycodone Extended Release (ER), remains on our commercial group and individual formulary at Tier 2. 

What does it treat?

OxyContin is used to relieve severe pain and prescribed when other pain medicines are ineffective or can’t be tolerated.